This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Bottomley, J. Search for Related Content Social Bookmarking                         What's this?

Economic costs of diabetes in the US in 2007 — Implications for Europe

Bottomley Amygdala Ltd, The Warren, Willian Road, Letchworth Garden City, Hertfordshire, SG6 2AA, UK, jmb{at}amygdala.uk.com

In March 2008 the latest American Diabetes Association (ADA) commissioned economic study of the costs of diabetes in 2007 was published. The economic burden of diabetes was quantified in terms of its increased healthcare resource use (direct costs) and lost productivity (indirect costs) and provided a detailed breakdown of the costs attributed to diabetes. In the five years since the ADA published a similar analysis, the number of Americans with diagnosed diabetes has risen from 12.1 to 17.1 million and the economic cost has risen from $132 billion (equivalent to $153 billion in 2007 dollars) to $174 billion. This major analysis is reviewed and the implications for Europe are considered. The findings are similar to those described in earlier US studies and also landmark European economic studies in diabetes. The results are also discussed in the context of the well accepted association of type 2 diabetes and overweight and obesity and because obesity has reached epidemic proportions in developed and developing countries

Key Words: cost-effectiveness • cost of illness • guidelines obesity • type 2 diabetes.

References

• American Diabetes Association: Economic costs of diabetes in the US in 2007. Diabetes Care 2008;31:596-615.[Abstract/Free Full Text]
• American Diabetes Association: Economic consequences of diabetes in the US, in 1997. Diabetes Care 1998;21:296-309.[Abstract]
• Hogan P., Dall T., Nikolov P. Economic costs of diabetes in the US in 2002. Diabetes Care 2003;26:917-32.[Abstract/Free Full Text]
• Clabaugh G., Ward MM Cost of illness studies in the US: A systematic review of methodologies used for direct cost. Value In Health 2008; 11:13-21.[Web of Science][Medline] [Order article via Infotrieve]
• Jönsson B. revealing the cost of type II diabetes in Europe. Diabetologia 2002;45:S5-S12.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Williams R., Baxter H., Bottomley J. et al. CODE-2*UK: Our contribution to a European Study of the costs of type 2 diabetes. Pract Diabetes International 2001;18:235-8.[CrossRef]
• Williams R., Van Gaal L., Lucioni C. Assessing the impact of complications on the costs of type II diabetes. Diabetologia 2002;45:S13-S17. 8. Koopmanschap M. Coping with type II diabetes: the patient's perspective. Diabetologia 2002;45:S18-S22.[Web of Science][Medline] [Order article via Infotrieve]
• Gray A., Fenn P., McGuire A. The cost of insulin-dependent diabetes mellitus (IDDM) in England and Wales. Diabet Med 1995;12:1068-76.[Web of Science][Medline] [Order article via Infotrieve]
• Bottomley JM on behalf of the T2ARDIS Steering Committee. Managing care of type 2 diabetes. Learnings from T2ARDIS. Br J Diabetes Vasc Dis 2001;1:68-72.[Abstract/Free Full Text]
• Bagust A., Beale S. Modelling EuroQol health-related utility values for diabetic complications from CODE-2 data. Health Econ 2005;14:217-30.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Clarke P., Gray A., Holman R. Estimating utility values for health states of type 2 diabetic patients using the EQ-5D UKPDS 62. Medical Decision Making 2002;22:340-9.[Abstract/Free Full Text]
• Coffey JT, Brändle M., Zhou H. et al. Valuing health-related quality of life in diabetes. Diabetes Care 2002;25:2238-43.[Abstract/Free Full Text]
• Holmes J., Gear E., Bottomley J. et al. Do people with type 2 diabetes and their carers lose income? (T2ARDIS-4). Health Policy 2003;64:291-6. 15. Brouwer WBF. Too important to ignore. Informal caregivers and other significant others. Pharmacoeconomics 2006;24:39-41.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Diabetes Atlas, third edition. International Diabetes Federation, Brussels, 2006 (http://www.eatlas.idf.org).
• Weiss R., Caprio S. The metabolic consequences of childhood obesity. Best Pract Res Clin Endocrinol Metab 2005;19:405-19.[CrossRef][Medline] [Order article via Infotrieve]
• WHO European Ministerial Conference on Counteracting Obesity. Diet and physical activity for health. Istanbul, November 2006. The challenge of obesity in the WHO European Region and the strategies for response.http://www.euro.who.int/Document/NUT/Instanbul_conf_edoc06.pdf [accessed 2 April 2008]
• Department of Health - Economic and operational research. Life expectancy projections, Government Actuary's Department: estimated effect of obesity (based on straight line extrapolation of trends).
• London, The Stationery Office 2004. 20. Finkelstein EA, Brown DS, Trogdon JG et al. Age-specific impact of obesity on prevalence and costs of diabetes and dyslipidemia. Value in Health 2007;10(supplement 1):S45-S51[CrossRef]
• Pinhas-Hamiel O., Zeitler P. The global spread of type 2 diabetes mellitus in children and adolescents. J Pediatr 2005;146:693-700.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Buse JB, Ginsberg HN, Bakris GL et al. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Diabetes Care 2007;30:162-72.[Abstract/Free Full Text]
• The task force on diabetes and cardiovascular diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD). Guidelines on diabetes, pre-diabetes and cardiovascular diseases: Full text. www.escardio.organdwww.easd.org.
• Krentz AJ Management of type 2 diabetes in the obese patient: Current concerns and emerging therapies. Curr Med Res Opin 2008;24:401-17[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Dixon JB, O'Brien PE, Playfair J. et al. Adjustable gastric banding and conventional therapy for type 2 diabetes. A randomised controlled trial. JAMA 2008;299:316-23.[Abstract/Free Full Text]
• Bottomley JM, Raymond FD Pharmacoeconomic issues for diabetes therapy. Best Pract & Res Clin Endocrinol & Metab 2007;21:657-85.[CrossRef][Medline] [Order article via Infotrieve]
• Obesity. Guidance on the prevention, identification, assessment and management of overweight and obesity in adults and children. NICE December 2006. Availableatwww.nice.org.uk
• Rimonabant for the treatment of overweight and obese patients: Final appraisal determination (26 March 2008) http://www.nice.org.uk/guidance/index.jsp?action=download&o=40050.
• O'Rahilly S. Non-insulin-dependent diabetes mellitus: the gathering storm. BMJ 1997;314:955-9.[Free Full Text]

The British Journal of Diabetes & Vascular Disease, Vol. 8, No. 2, 96-100 (2008)
DOI: 10.1177/14746514080080020801


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				J C. Agwu Screening for type 2 diabetes mellitus in children and adolescents The British Journal of Diabetes & Vascular Disease, July 1, 2008; 8(4): 163 - 168. [Abstract] [PDF]

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Bottomley, J. Search for Related Content Social Bookmarking                         What's this?